Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.02.2024 | Seed | $12M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 24.02.2024 | Insamo Raises $12 Million To Pioneer The Discovery Of Membra... | Insamo – a biotechnology company pioneering the discovery of membrane-permeable and orally available... | pulse2.com... |
| 23.02.2024 | Insamo's $12M Seed Funding Sparks Innovation in Biotechnolog... | Insamo, a Berkeley-based biotechnology company, recently secured $12 million in seed funding, igniti... | parsers.vc... |
| 21.02.2024 | Insamo Raises $12M in Seed Funding | From left to right: Tim Craven (CEO); Toby Passioura (CSO); Glen McIntyre (COO). (Photo: Business Wi... | finsmes.co... |
| 21.02.2024 | Insamo Launches with $12M Funding |
BERKELEY, CA, Insamo, a biotechnology company, announced $12 million in seed capital.
>> Cl... | vcnewsdail... |
| 21.02.2024 | Exclusive: How emerging manager Overture VC raised $60 milli... | Fundraising right now is zero fun.
Obvious, I know, but it bears repeating—if you’re a VC, especiall... | fortune.co... |
| - | Insamo | “Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally ... | fastfounde... |
Reviews 0
